Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect on antiviral activity of Videx EC in asymptomatic HIV infection
2004-002565-20Phase 4Active
- Sponsor
- Asociación para el Estudio de las Enfermedades Infecciosas
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of didanosine in human immunodeficiency virus infection (HIV), sponsored by Asociación para el Estudio de las Enfermedades Infecciosas. Primary endpoint: Decrease in plasma viral load at 1 month. Started Oct 2004; status: active.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2004-002565-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002565-20.